BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20615952)

  • 1. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands.
    de Medina P; Paillasse MR; Segala G; Poirot M; Silvente-Poirot S
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13520-5. PubMed ID: 20615952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of the microsomal tamoxifen binding site.
    Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
    J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol epoxide hydrolase and cancer.
    Silvente-Poirot S; Poirot M
    Curr Opin Pharmacol; 2012 Dec; 12(6):696-703. PubMed ID: 22917620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From tamoxifen to dendrogenin A: The discovery of a mammalian tumor suppressor and cholesterol metabolite.
    Silvente-Poirot S; de Medina P; Record M; Poirot M
    Biochimie; 2016 Nov; 130():109-114. PubMed ID: 27262406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands.
    de Medina P; Paillasse MR; Ségala G; Khallouki F; Brillouet S; Dalenc F; Courbon F; Record M; Poirot M; Silvente-Poirot S
    Chem Phys Lipids; 2011 Sep; 164(6):432-7. PubMed ID: 21641337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells.
    Segala G; de Medina P; Iuliano L; Zerbinati C; Paillasse MR; Noguer E; Dalenc F; Payré B; Jordan VC; Record M; Silvente-Poirot S; Poirot M
    Biochem Pharmacol; 2013 Jul; 86(1):175-89. PubMed ID: 23500540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.
    Payré B; de Medina P; Boubekeur N; Mhamdi L; Bertrand-Michel J; Tercé F; Fourquaux I; Goudounèche D; Record M; Poirot M; Silvente-Poirot S
    Mol Cancer Ther; 2008 Dec; 7(12):3707-18. PubMed ID: 19074846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.
    Watts CK; Sutherland RL
    Biochem J; 1986 Jun; 236(3):903-11. PubMed ID: 3790095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation.
    de Medina P; Silvente-Poirot S; Poirot M
    Autophagy; 2009 Oct; 5(7):1066-7. PubMed ID: 19738414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity binding sites for oxygenated sterols in rat liver microsomes: possible identity with antiestrogen binding sites.
    Hwang PL
    Biochim Biophys Acta; 1990 Feb; 1033(2):154-61. PubMed ID: 2306459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cholesterol-5,6-Epoxide Hydrolase: A Metabolic Checkpoint in Several Diseases.
    de Medina P; Ayadi S; Diallo K; Buñay J; Pucheu L; Soulès R; Record M; Brillouet S; Vija L; Courbon F; Silvente-Poirot S; Poirot M
    Adv Exp Med Biol; 2024; 1440():149-161. PubMed ID: 38036879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site.
    Mésange F; Sebbar M; Kedjouar B; Capdevielle J; Guillemot JC; Ferrara P; Bayard F; Delarue F; Faye JC; Poirot M
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):107-12. PubMed ID: 9693109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, cholestane-3β,5α,6β-triol and 6-oxo-cholestan-3β,5α-diol recovery for quantification by GC/MS.
    Soules R; Noguer E; Iuliano L; Zerbinati C; Leignadier J; Rives A; de Medina P; Silvente-Poirot S; Poirot M
    Chem Phys Lipids; 2017 Oct; 207(Pt B):92-98. PubMed ID: 28554594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor.
    Kedjouar B; Daunes S; Vilner BJ; Bowen WD; Klaebe A; Faye JC; Poirot M
    Biochem Pharmacol; 1999 Dec; 58(12):1927-39. PubMed ID: 10591147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two tamoxifen target proteins by photolabeling with 4-(2-morpholinoethoxy)benzophenone.
    Mésange F; Sebbar M; Capdevielle J; Guillemot JC; Ferrara P; Bayard F; Poirot M; Faye JC
    Bioconjug Chem; 2002; 13(4):766-72. PubMed ID: 12121132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.
    Leignadier J; Dalenc F; Poirot M; Silvente-Poirot S
    Biochem Pharmacol; 2017 Nov; 144():18-28. PubMed ID: 28642035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical synthesis and biochemical properties of cholestane-5α,6β-diol-3-sulfonate: A non-hydrolysable analogue of cholestane-5α,6β-diol-3β-sulfate.
    de Médina P; Ayadi S; Soulès R; Payre B; Rup-Jacques S; Silvente-Poirot S; Samadi M; Poirot M
    J Steroid Biochem Mol Biol; 2023 Nov; 234():106396. PubMed ID: 37683773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS).
    Poirot M; De Medina P; Delarue F; Perie JJ; Klaebe A; Faye JC
    Bioorg Med Chem; 2000 Aug; 8(8):2007-16. PubMed ID: 11003145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor.
    Voisin M; de Medina P; Mallinger A; Dalenc F; Huc-Claustre E; Leignadier J; Serhan N; Soules R; Ségala G; Mougel A; Noguer E; Mhamdi L; Bacquié E; Iuliano L; Zerbinati C; Lacroix-Triki M; Chaltiel L; Filleron T; Cavaillès V; Al Saati T; Rochaix P; Duprez-Paumier R; Franchet C; Ligat L; Lopez F; Record M; Poirot M; Silvente-Poirot S
    Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9346-E9355. PubMed ID: 29078321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.